CRH | Corticotropin releasing hormone | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CRK | V-crk avian sarcoma virus CT10 oncogene homolog | Predicted intracellular proteins
| | | | | Expressed in all |
CRY1 | Cryptochrome circadian clock 1 | Predicted intracellular proteins
| | | | | Expressed in all |
CRY2 | Cryptochrome circadian clock 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CYB5R4 | Cytochrome b5 reductase 4 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
DOC2B | Double C2-like domains, beta | Predicted intracellular proteins
| | | | | Mixed |
DOK2 | Docking protein 2, 56kDa | Predicted intracellular proteins
| | | | | Mixed |
DOK3 | Docking protein 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
DOK4 | Docking protein 4 | Predicted intracellular proteins
| | | | | Expressed in all |
DOK6 | Docking protein 6 | Predicted intracellular proteins
| | | | | Mixed |
DOK7 | Docking protein 7 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DRD2 | Dopamine receptor D2 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
EEF2K | Eukaryotic elongation factor-2 kinase | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
EFNA5 | Ephrin-A5 | Cancer-related genes Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
EGR2 | Early growth response 2 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
EIF4B | Eukaryotic translation initiation factor 4B | Predicted intracellular proteins
| | | | | Expressed in all |
EIF4E | Eukaryotic translation initiation factor 4E | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
EIF4G1 | Eukaryotic translation initiation factor 4 gamma, 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
EPHA5 | EPH receptor A5 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
EPM2AIP1 | EPM2A (laforin) interacting protein 1 | Predicted intracellular proteins
| | | | | Expressed in all |
ERO1LB | ERO1-like beta (S. cerevisiae) | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
FABP2 | Fatty acid binding protein 2, intestinal | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
FABP3 | Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) | Candidate cardiovascular disease genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
FADS1 | Fatty acid desaturase 1 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
FAM3B | Family with sequence similarity 3, member B | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FAM3D | Family with sequence similarity 3, member D | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FETUB | Fetuin B | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
FFAR3 | Free fatty acid receptor 3 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FFAR4 | Free fatty acid receptor 4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Group enriched |
FGF10 | Fibroblast growth factor 10 | Disease related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGF16 | Fibroblast growth factor 16 | Disease related genes Predicted intracellular proteins RAS pathway related proteins
| | | | | Not detected |
FGF17 | Fibroblast growth factor 17 | Cancer-related genes Disease related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FGF18 | Fibroblast growth factor 18 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGF19 | Fibroblast growth factor 19 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FGF2 | Fibroblast growth factor 2 (basic) | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
FGF20 | Fibroblast growth factor 20 | Disease related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
FGF22 | Fibroblast growth factor 22 | Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
FGF23 | Fibroblast growth factor 23 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FGF3 | Fibroblast growth factor 3 | Cancer-related genes Disease related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Not detected |
FGF4 | Fibroblast growth factor 4 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Not detected |
FGF5 | Fibroblast growth factor 5 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGF6 | Fibroblast growth factor 6 | Cancer-related genes Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enriched |
FGF7 | Fibroblast growth factor 7 | Cancer-related genes Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGF8 | Fibroblast growth factor 8 (androgen-induced) | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Not detected |
FGF9 | Fibroblast growth factor 9 | Cancer-related genes Disease related genes Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGFR1 | Fibroblast growth factor receptor 1 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
FGFR2 | Fibroblast growth factor receptor 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FGFR4 | Fibroblast growth factor receptor 4 | Cancer-related genes CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |